Vraylar 3 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FWFQ3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,706
Award facts
- Contract value 100% obligated
- $28,706.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $28,706.16 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Vraylar 3 mg capsules (30-count units). This is a firm fixed price, non-set-aside contract with a completion date of September 10, 2025, and performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products, medical supplies, brand-name and generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Vraylar—a neurological treatment medication—exemplifies the company's role in fulfilling specialized pharmaceutical needs within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FWFQ3?
SPE2DB25FWFQ3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FWFQ3 worth?
The government has obligated $28,706 on SPE2DB25FWFQ3.
Is contract SPE2DB25FWFQ3 an order under another contract?
Yes. SPE2DB25FWFQ3 is a delivery order under SPE2DB24D1034, an indefinite delivery contract.
Was contract SPE2DB25FWFQ3 competed?
The extent of competition for SPE2DB25FWFQ3 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award